Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK

This page shows the latest Cancer Research UK news and features for those working in and with pharma, biotech and healthcare.

CRUK forges £30m ‘post-Brexit’ R&D alliance

CRUK forges £30m ‘post-Brexit’ R&D alliance

Cancer Research UK has joined forces with two peer organisations in Italy and Spain to fund half a dozen R&D projects – and to show that Brexit need not be a ... Our Accelerator Award funding will lay the groundwork for a Europe and UK research pipeline

Latest news

  • London cancer hub launched by Cancer Research UK London cancer hub launched by Cancer Research UK

    London cancer hub launched by Cancer Research UK. Specialist centres unite to collaborate on immunotherapies such as CAR-T. ... An ambitious plan to turn London into a ‘powerhouse’of cancer research has been launched, backed with £14m ($18m) in

  • UK start-up Azeria emerges with £4m drug discovery pot for cancer UK start-up Azeria emerges with £4m drug discovery pot for cancer

    UK start-up Azeria emerges with £4m drug discovery pot for cancer. ... A new UK biotech, Azeria Therapeutics, has been set up to build on scientific discoveries coming out of Cancer Research UK’s lab at the University of Cambridge.

  • Can a post-Brexit UK stay aligned with Europe on clinical research? Can a post-Brexit UK stay aligned with Europe on clinical research?

    The MHRA document came shortly before medical charity Cancer Research UK published its take on how Brexit will affect clinical trials, including the importance of the UK staying aligned with the ... This important report sets out just why we must take

  • Cancer Research UK to test Asterias’ lung cancer vaccine Cancer Research UK to test Asterias’ lung cancer vaccine

    Cancer Research UK to test Asterias’ lung cancer vaccine. The vaccine could treat NSCLC patients who are at risk of relapse. ... Cancer Research UK is starting a clinical trial of a first-of-its-kind vaccine for non-small cell lung cancer (NSCLC) based

  • AstraZeneca expands alliance with Bicycle Therapeutics AstraZeneca expands alliance with Bicycle Therapeutics

    The initial deal was signed 18 months ago and focused on using the UK biotech’s bicyclic peptide platform to develop drugs against multiple disease targets, none of which are being ... The biotech’s lead candidate is BT1718 for solid tumours, which

More from news
Approximately 15 fully matching, plus 122 partially matching documents found.

Latest Intelligence

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Scientists from the UK’s Medical Research Council Laboratory of Molecular Biology – which pioneered the sequencing of DNA – are already working with AstraZeneca counterparts and they will have places in the ... The park is also home to the Cancer

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    up innate immune responses, and Cancer Research UK is repurposing an AZ chemokine CCR4 receptor drug (AZD2098) originally developed for asthma in kidney cancer. ... Additional work is going to stratify tumours according to these molecular signatures, and

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of

  • Communicating health messages Communicating health messages

    Consider this impactful infographic from Cancer Research UK:. Now take a look at how such comparisons are normally presented in the media. ... them? They are human too. Source: Cancer Research UK. How data is framed can incite behaviour change .

  • EATRIS and the new age of partnering EATRIS and the new age of partnering

    In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... to happen so we have the good political support underlined with

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Glythera strengthens its scientific advisory board and appoints CSO. Dr Robert Lutz and Dr Jon Roffey join the UK biotech. ... Additionally, Dr Jon Roffey joins Glythera ’s scientific advisory board (SAB) from Cancer Research Technology (CRT), Cancer

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

  • Cancer Research UK's Karen Vousden to join BMS board Cancer Research UK's Karen Vousden to join BMS board

    Cancer Research UK's Karen Vousden to join BMS board. She will also serve on the pharma firm's Science and Technology Committee. ... Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

  • Sophie Adlard joins J+D Consulting as a business analyst Sophie Adlard joins J+D Consulting as a business analyst

    Sophie Adlard joins J D Consulting as a business analyst. She brings experience from Cancer Research UK, where she was a PhD student. ... market research and forecasting projects going forward.”.

  • Hollingsworth leaves cancer charity for ABPI Hollingsworth leaves cancer charity for ABPI

    Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British Pharmaceutical Industry (ABPI). ... He leaves his role as public affairs manager at Cancer Research UK.

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer

    In spite of this, pancreatic cancer research is chronically underfunded and awareness is low, in part because of widespread misconceptions regarding the disease. ... Indeed, the disease receives only 3% of UK cancer research funding [6], and a patient

  • Why is the UK lagging behind the rest of Europe in cancer survival?

    Why is the UK lagging behind the rest of Europe in cancer survival? ... Say Communications, London healthcare PR agency, discusses the latest technologies that will improve cancer survival rates in UK.

  • World Cancer Day and the role of people-centred care

    Overview on Patient Centricity in Cancer Care. Front Pharmacol 2017; 8: 1-12. ... BMJ Innov 2017; 3(2): 76-83. World Cancer Day. Available at: . Accessed February 2018. Cancer Research UK. Available at: . Accessed February 2018.

  • Caring for prostate cancer patients

    Cancer Research UK estimates that  men in the UK have a 1 in 8 chance of developing prostate cancer at some point in their lives. ... From a personal perspective, I’ ve watched my grandfather receive his diagnosis of prostate cancer.

  • When is sun safety doing more harm than good?

    New figures from  Cancer Research UK warn that people over 65 are around seven times more likely to develop malignant melanoma - a type of skin cancer - compared to 40 years ago. ... Thankfully campaigns from charities such as Cancer Research UK that

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics